股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 榮尊國際控股集團有限公司 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01780 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 620,000,000 | | 0 | | 620,000,000 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 620,000,000 | | 0 | | 620,000,000 | 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | ...

Core Viewpoint - On October 31, Hong Kong Stock Exchange data indicates that shareholders of Rongzun International Holdings (01780) transferred stocks from Jietao Securities to Beta International Securities, with a total market value of HKD 435 million, accounting for 43.81% of the shares [1] Group 1 - On October 28, Rongzun International Holdings announced that the board was informed by Dr. Jin Zibo that, according to the terms of the placement agreement, all 372 million placement shares (representing 60% of the company's existing issued share capital as of the announcement date) were successfully placed by the placement agent at a price of HKD 0.446 per share to 12 subscribers [1] - The settlement of the placement shares under this private placement occurred on October 28, 2025 [1]

Core Insights - On October 31, shareholders of Rongzun International Holdings (01780) transferred shares from Jietao Securities to Beta International Securities, with a total market value of HKD 435 million, representing 43.81% of the shares [1] Group 1 - On October 28, Rongzun International Holdings announced that the board was informed by Dr. Jin Zibo that, according to the terms of the placement agreement, all 372 million placement shares (60% of the company's existing issued share capital as of the announcement date) were successfully placed by the placement agent at a price of HKD 0.446 per share to 12 subscribers [1] - The settlement of the placement shares under this private placement occurred on October 28, 2025 [1]

Core Viewpoint - Rongzun International Holdings (01780) successfully placed 372 million shares, representing 60% of the company's existing issued share capital, at a price of HKD 0.446 per share to 12 subscribers [1] Group 1 - The placement settlement occurred on October 28, 2025 [1] - All subscribers confirmed their independence from the company and have no association with it [1] - A clause in the placement agreement restricts any subscriber from holding 30% or more of the company's issued share capital post-placement, preventing mandatory general offer obligations under the Takeovers Code [1] Group 2 - After the completion of the placement, Mr. Liu Saijian and Dr. Kaneko hold 93 million shares, accounting for 15% of the total issued share capital [1] - Consequently, Mr. Liu Saijian, Dr. Kaneko, and the seller are no longer considered controlling shareholders of the company as per listing rules [1]

于完成后，柳濑健一先生及金子博博士通过卖方持有9300万股股份，占公司已发行股本总额的15%。因 此，柳濑健一先生、金子博博士及卖方均不再是本公司(按上市规则的定义)的控股股东。 智通财经APP讯，荣尊国际控股(01780)发布公告，董事会获金子博博士知会，根据配售协议的条款，所 有3.72亿股配售股份(占本公告日期公司现有已发行股本的60%)，已由配售代理以每股0.446港元的价格 成功配售予12名承配人，而此次私人配售项下的配售股份结算已于2025年10月28日进行。据配售代理告 知，各承配人均已确认其独立于公司且与公司无关联。配售协议的一项条款是，任何承配人(连同与其 一致行动的人士)在私人配售完成后即时，不得持有公司已发行股本总额的30%或以上，亦不得因而触 发《公司收购及合并守则》第26.1条就公司股份作出强制性全面收购要约的责任。 ...

格隆汇10月28日丨荣尊国际(01780.HK)公布，董事会获金子博知会，根据配售协议的条款，所有3.72亿 股配售股份(占公告日期公司现有已发行股本的60%)，已由配售代理以每股0.446港元的价格成功配售予 12名承配人，而此次私人配售项下的配售股份结算已于2025年10月28日进行。 于完成后，柳濑健一及金子博通过卖方持有9300万股股份，占公司已发行股本总额的15%。因此，柳濑 健一、金子博及卖方均不再是公司的控股股东。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 對 因 本 公 告 全 部 或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 RONGZUN INTERNATIONAL HOLDINGS GROUP LIMITED 榮尊國際控股集團有限公司 （於開曼群島註冊成立的有限責任公司） （股份代號：1780） 內幕消息 茲提述本公司於2025年10月21日 就 有 關 私 人 配 售 事 宜 所 發 佈 的 公 告（「該公告」）。 除文義另有所指外，本公告所用詞匯與該公告所界定者具有相同涵義。 完成私人配售事項 董事會獲金子博博士知會，根據配售協議的條款，所有372,000,000股 配 售 股 份（佔 本公告日期本公司現有已發行股本的60%），已 由 配 售 代 理 以 每 股0.446港元的價 格成功配售予12名 承 配 人，而 此 次 私 人 配 售 項 下 的 配 售 股 份 結 算（「完 成」）已 於 2025年10月28日進行。據配售代理告知，各承配人均已確認其獨立於 ...

Core Insights - The article emphasizes the long-term value of consumer investment despite recent challenges in the sector, suggesting that the current market conditions may present new opportunities for those who remain committed [1][3] Investment Strategy Adjustments - The company has expanded its investment focus to include sectors like biomedicine and low-altitude economy, categorizing consumer investments into technology and non-technology segments [1] - A shift in investment strategy has occurred, moving away from reliance on IPOs as the primary exit strategy due to the lengthy IPO process, which could take up to 50 years for all potential exits based on current rates [1][2] New Investment Approaches - The establishment of a merger and acquisition (M&A) fund is highlighted, targeting projects from diversified groups, "first-generation" entrepreneurs, and serial entrepreneurs who prefer selling businesses rather than taking them public [4] - The company is also pursuing an industrial integration fund, collaborating with industry leaders and local governments to launch investment funds focused on early and growth-stage companies [5] - A dividend strategy has been introduced, exemplified by the launch of a SPAC product in Macau, which utilizes a revenue-sharing model to invest in profitable businesses with strong cash flows [6][10] Market Outlook - The adjustments in strategy have opened up new investment opportunities that were previously inaccessible under an IPO-focused approach, allowing for a broader range of potential assets [9] - The company anticipates that these new strategies, including the industrial integration fund, M&A fund, and revenue-sharing products, will gain traction and lead to significant returns in the future [13]

Major Events - Guanghe Tong (00638) has set the offer price at HKD 21.5 per share, with the public offering receiving a subscription rate of 550.99 times [1] - China Biologic Products (01177) announced the Phase III study data of Kymriah combined with Fluvestrant for the first-line treatment of advanced breast cancer will be presented at ESMO 2025 [1] - Derun Holdings (01709) plans to conduct a placement of new shares at a discount of approximately 11.34%, aiming to raise about HKD 761 million [1] - New World Development (00017) clarified media reports, stating that it has not undertaken any debt management projects regarding perpetual and other debt securities [1] - China Shenhua (01088) reported that Unit 4 of the Jiujiang Phase II project has successfully completed a 168-hour trial run [1] - Jingwei TianDi (02477) has acquired a TCSP licensed company and launched a new feature called FOPAY [1] - Rongzun International Holdings (01780) announced that its controlling shareholder intends to place up to 60% of the company's shares, reducing their stake to 15% [1] Financial Performance - Pop Mart (09992) reported a year-on-year revenue growth of 245%-250% for the third quarter [2] - China Telecom (00728) recorded a profit attributable to shareholders of RMB 30.8 billion for the first three quarters, reflecting a year-on-year increase of 5.0% [2] - Luk Fook Holdings (00590) reported that its overall retail value, retail income, and same-store sales for the second quarter exceeded the first quarter, increasing by 18%, 15%, and 10% respectively [2] - Minmetals Resources (01208) produced a total of 127,000 tons of copper in the third quarter, marking an 11% year-on-year increase [2] - Datang Power (00991) achieved a total electricity generation of approximately 2,062.41 billion kilowatt-hours in the first three quarters, up about 2.02% year-on-year [2] - Far East Horizon (03360) reported an increase in profit attributable to ordinary shareholders for the first three quarters [2] - China General Nuclear Power Corporation (01164) produced a total of 644.3 tons of natural uranium in the third quarter [2]

于本公告日期，该3.72亿股配售股份相当于公司现有已发行股本的60%。假设所有配售股份均成功配售 予承配人，待配售事项完成后，Kyosei Technology Inc.于融尊国际控股集团有限公司的持股将减少至 9300万股股份，相当于公司已发行股本总额的15%。因此，金子博、柳濑健一或卖方均将不再为公司的 控股股东。 格隆汇10月21日丨荣尊国际(01780.HK)公告，公司董事会获公司执行董事及主要股东金子博(告知，由 金子博持有28.05%及柳濑健一持有65.45%的Kyosei Technology Inc.(卖方)于2025年10月21日与结好证券 有限公司(配售代理)订立配售协议，据此，配售代理已同意尽最大努力促使投资者按每股不少于0.446港 元的价格购买卖方持有的合共最多3.72亿股公司现有股份。配售期间将由配售协议日期起开始，并于以 下较早者结束：(i)2025年10月28日星期二下午五时正；或(ii)配售代理收到承配人认购合共不少于3.72亿 股配售股份的购买订单的时间及日期，或卖方与配售代理可能书面协定的其他时间及╱或日期。 ...